EPO treatment in animal models show EPO regulation of glucose homeostasis and obesity associated fat mass and inflammation with contributions from genetic background, sex and expression of EPOR in non-hematopoietic tissue such as fat and brain, and support the potential benefit of EPO in metabolic regulation for human health. The gene discussed is EPO; the disease is obesity due to melanocortin 4 receptor deficiency.